Last reviewed · How we verify
NCT07133503
Radiological Evaluation of Anterior Maxilla For Immediate Implant Placement
trial testing radiological evaluation in Maxillary Retrusion in 278 participants. Completed in 1 May 2025.
1 January 2025
Quick facts
| Lead sponsor | TC Erciyes University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 278 |
| Start date | 1 January 2024 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- radiological evaluation
Conditions studied
- Maxillary Retrusion — all drugs for Maxillary Retrusion →
Sponsor
TC Erciyes University
Who can join
Adults 20 to 80, any sex, with Maxillary Retrusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to the literature age and gender may be associated with differences in skeletal size, anatomy and architecture in humans. However, little is known about the synergistic effects of age and gender on the healing capacity of maxillary bones, since most of the preclinical studies are focused on each variable separately. The present study radiologically evaluated various parameters such as alveolar crest height and width, buccal bone thickness, degree of buccal undercut, and root-crest angle using cone-beam computed tomography (CBCT) in a large patient population, and compared these parameters across different age and gender groups to analyze the effect of aging and gender on the bone morphology in the anterior maxillary region.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07133503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of radiological evaluation
Trials testing the same drug.
- NCT05543304 — Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) · unknown
- NCT05556434 — Predicting Complications of Hepatolithiasis After Hepatectomy · unknown
Other recruiting trials for Maxillary Retrusion
Currently open trials in the same condition.
- NCT05446714 — Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE) · NA · active not recruiting
Other TC Erciyes University trials
Trials by the same sponsor.
- NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
- NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
- NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
- NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07133503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
- Last refreshed: 21 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07133503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing